PATIENTS WITH RHEUMATOID ARTHRITIS WHO DEVELOP SARCOPENIA FALL FREQUENTLY: 5-YEAR DATA FROM THE CHIKARA STUDY

被引:0
|
作者
Yamada, Y. [1 ]
Tada, M. [2 ]
Mandai, K. [3 ]
Hidaka, N. [2 ]
Nakamura, H. [1 ]
机构
[1] Osaka City Univ, Orthoped, Sch Med, Osaka, Japan
[2] Osaka City Gen Hosp, Orthoped, Osaka, Japan
[3] Saiseikai Nakatsu Hosp, Orthoped, Osaka, Japan
关键词
D O I
10.1136/annrheumdis-2022-eular.1686
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0262
引用
收藏
页码:1257 / 1258
页数:2
相关论文
共 50 条
  • [21] Stable mental and physical disease course in a 5-year longitudinal study of patients with rheumatoid arthritis.
    Uhlig, T
    Smedstad, LM
    Kvien, TK
    Vaglum, P
    Moum, T
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S222 - S222
  • [22] THE STABILITY OF HEALTH-STATUS IN RHEUMATOID-ARTHRITIS - A 5-YEAR STUDY OF PATIENTS WITH ESTABLISHED DISEASE
    MEENAN, RF
    KAZIS, LE
    ANDERSON, JJ
    AMERICAN JOURNAL OF PUBLIC HEALTH, 1988, 78 (11) : 1484 - 1487
  • [23] IMPACT OF GOLIMUMAB ON PHYSICAL FUNCTION AND EMPLOYABILITY OF PATIENTS WITH RHEUMATOID ARTHRITIS: 5-YEAR DATA FROM 3 PHASE III CLINICAL TRIALS
    Han, C.
    Keystone, E.
    Fleischmann, R.
    Smolen, J.
    Matteson, E. L.
    Emery, P.
    Genovese, M.
    Gathany, T.
    Hsia, E. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 234 - 234
  • [24] COMPARATIVE ANALYSIS OF ESTIMATED BONE MASS AND BONE MINERAL DENSITY IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM THE CHIKARA STUDY
    Mandai, Koji
    Yamada, Yutaro
    Koike, Tatsuya
    Okano, Tadashi
    Hidaka, Noriaki
    Tada, Masahiro
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1625 - 1626
  • [25] Impact of Golimumab on Physical Function and Employability of Patients with Rheumatoid Arthritis: 5-Year Data from 3 Phase III Clinical Trials
    Han, Chenglong
    Keystone, Edward C.
    Fleischmann, Roy
    Smolen, Josef S.
    Matteson, Eric L.
    Emery, Paul
    Genovese, Mark C.
    Gathany, Timothy A.
    Hsia, Elizabeth C.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1090 - S1090
  • [26] Early suppression of spreading of arthritis predicts 5-year remission in patients with early rheumatoid arthritis.
    Leirisalo-Repo, M
    Kautiainen, H
    Mottonen, T
    Hannonen, P
    Nissila, M
    Korpela, M
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S288 - S288
  • [27] Prevalence of adverse reactions to intravenously administered originator biologics in patients with rheumatoid arthritis: A 5-year retrospective study
    Almalag, Haya M.
    Alaujan, Shiekha S.
    Alhazzani, Hawazin S.
    Alzamel, Lamia A.
    Tashkandi, Reem S.
    Alarfaj, Hussain F.
    Alarfaj, Abdurhman S.
    Omair, Mohammed A.
    SAUDI PHARMACEUTICAL JOURNAL, 2022, 30 (07) : 1044 - 1051
  • [28] HEALTH-STATUS AS A PREDICTOR OF MORTALITY IN RHEUMATOID-ARTHRITIS - A 5-YEAR STUDY
    KAZIS, LE
    ANDERSON, JJ
    MEENAN, RF
    JOURNAL OF RHEUMATOLOGY, 1990, 17 (05) : 609 - 613
  • [29] Assessment of long-term safety and efficacy of etanercept in a 5-year extension study in patients with rheumatoid arthritis
    Klareskog, L.
    Gaubitz, M.
    Rodriguez-Valverde, V.
    Malaise, M.
    Dougados, M.
    Wajdula, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 238 - 247
  • [30] Association Between Medications and Herpes Zoster in Japanese Patients with Rheumatoid Arthritis: A 5-year Prospective Cohort Study
    Harada, Sayoko
    Sakai, Ryoko
    Hirano, Fumio
    Miyasaka, Nobuyuki
    Harigai, Masayoshi
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (07) : 988 - 995